India–EU Trade Deal: Impact on the European Pharmaceutical Market and Consulting Opportunities for Indian Companies
India–EU Trade Deal: Impact on the European Pharmaceutical Market and Consulting Opportunities for Indian Companies riarcompany.2025@gmail.com February 2, 2026 Europe Market Entry Strategy,Uncategorized Introduction The recently concluded India–EU Free Trade Agreement (FTA)—often described as the “Mother of All Trade Deals”—marks a pivotal shift in economic and strategic relations between India and the European Union. While […]
The New Pharma Playbook (2025–2030)
The New Pharma Playbook (2025–2030) riarcompany.2025@gmail.com January 29, 2026 Industry Insights & Thought Leadership,Uncategorized The pharmaceutical industry is entering a decisive decade. Traditional growth engines—blockbuster drugs, extended patent exclusivity, and large field sales forces—are no longer sufficient in a healthcare ecosystem defined by data transparency, patient empowerment, payer scrutiny, and rapid digital innovation. From 2025 […]
SFDA’s New Digital Health Regulatory Guidance (MDS-G27): What You Must Know
SFDA’s New Digital Health Regulatory Guidance (MDS-G27): What You Must Know riarcompany.2025@gmail.com January 14, 2026 Uncategorized The Saudi Food & Drug Authority (SFDA) has recently released MDS-G27, a new regulatory guidance for Digital Health Products, marking a significant shift in how digital health solutions are classified, assessed, and regulated in the Kingdom of Saudi Arabia. […]
SFDA Releases Version 3.0 of Verification & Abridged Pathways Guideline
SFDA Releases Version 3.0 of Verification & Abridged Pathways Guideline riarcompany.2025@gmail.com January 12, 2026 SFDA Regulatory Updates RIAR Consulting is pleased to share an important regulatory update from the Saudi Food & Drug Authority (SFDA) that will significantly impact pharmaceutical product registration and lifecycle management in Saudi Arabia. The SFDA has officially released Version 3.0 […]
A Complete Guide to SFDA Product Registration in Saudi Arabia — Insights from RIAR Consulting
A Complete Guide to SFDA Product Registration in Saudi Arabia — Insights from RIAR Consulting riarcompany.2025@gmail.com January 9, 2026 SFDA Product Registration – Saudi Arabia,Uncategorized Expanding into the Kingdom of Saudi Arabia (KSA) offers immense opportunities for life science, food, health, and consumer goods companies. However, Saudi Arabia’s regulatory ecosystem is governed by one authority […]
Why India Is Falling Behind China — and What Must Change to Achieve Competitive Parity
Why India Is Falling Behind China — and What Must Change to Achieve Competitive Parity riarcompany.2025@gmail.com January 8, 2026 Pharmaceutical Policy, Innovation & Compliance India and China represent two of the most influential forces in global pharmaceuticals. India is globally recognized as the “Pharmacy of the World”, supplying affordable medicines at unmatched scale. China, however, […]
SFDA Registration Made Simple: Why Riar Consulting Is the Trusted Regulatory Partner for Saudi Market Entry
SFDA Registration Made Simple: Why Riar Consulting Is the Trusted Regulatory Partner for Saudi Market Entry riarcompany.2025@gmail.com December 16, 2025 SFDA HOW WE HELP – SFDA Entering the Saudi Arabian healthcare and medical device market offers immense opportunity—but SFDA registration remains one of the most complex regulatory processes globally. From product classification to MDMA approvals, […]
Why Pharma Needs AI Now: The Industry’s Breakthrough Moment
It is a long established fact that a reader will be distracted by the readable.
A Student, a QA Professional, and a Start-up Founder Walk into the Future with RIAR VERA
It is a long established fact that a reader will be distracted by the readable.
The Hidden Cost of Regulatory Complexity in Pharma
It is a long established fact that a reader will be distracted by the readable.